Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats

@article{Yin2016LungspecificRI,
  title={Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats},
  author={Jie Yin and Shuling You and N. Li and Shouhai Jiao and Hesheng Hu and Mei Xue and Ye Wang and Wen-juan Cheng and Ju Liu and M. Xu and Suhua Yan and Xiaolu Li},
  journal={Respiratory Research},
  year={2016},
  volume={17}
}
BackgroundPulmonary arterial hypertension (PAH) is a progressive and life-threatening disease associated with high morbidity and mortality rates. However, the exact regulatory mechanism of PAH is unknown. Although coupling factor 6 (CF6) is known to function as a repressor, its role in PAH has not been explored. Here, we investigated the involvement of endogenous CF6 in the development of PAH.MethodsPAH was induced with monocrotaline (MCT), as demonstrated by significant increases in pulmonary… Expand
Role of P2X7R in the development and progression of pulmonary hypertension
TLDR
P2X7R contributes to the pathogenesis of PH, probably in association with activation of the NLRP3 inflammasome, and blockade of P2x7R might be applied as a novel therapeutic approach for the treatment of PAH. Expand
1,25(OH)2D3 attenuates pulmonary arterial hypertension via microRNA‐204 mediated Tgfbr2/Smad signaling
TLDR
It is demonstrated that 1,25(OH)2D3 was a promising therapeutic modality for treatment of PAH, function of which was exerted through miR‐204 mediated Tgfbr2 signaling. Expand
Polyclonal infection as a new scenario in Mycobacterium caprae epidemiology.
TLDR
Genotyping of serial M. caprae from herds with recurrent outbreaks enabled further discrimination of epidemiologically related isolates, supporting a clonal structure in Portugal and denoting the emergence of clonal diversity at the herd level, more apparent for MIRU4. Expand
Outbreak of tuberculosis in a closed setting: views on transmission based on results from molecular and conventional methods.
TLDR
Variation between the strains indicates that the outbreak may have arisen from several sources of infection, and variation in resistance indicates that rapid emergence of antimicrobial resistance is possible. Expand
The Influence of Bosentan on MicroRNA-27a/PPARγ/ET-1 Signaling Pathway in Pulmonary Artery Hypertension
TLDR
BST could competitively bind to ET-1 receptors and inhibit the miR-27a/PPARγ/ET-1 signaling pathway, thereby delaying the proliferation of PASMCs and affecting the development of PAH. Expand

References

SHOWING 1-10 OF 52 REFERENCES
Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents.
TLDR
Molecular blocking of the interaction between angiopoietin 1 and its endothelial receptor, TIE2, in the lung prevents pulmonary hypertension in 2 animal models of the disease and suggests a new strategy for understanding pulmonary hypertension based on the molecular biology of the pulmonary vascular wall. Expand
HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats
TLDR
The blockade of HMGB1 activity improved survival of MCT-induced PAH rats, and thus might be a promising therapy for the treatment of PAH. Expand
Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats
TLDR
This study demonstrated that the upregulation of CTGF in PASMCs following a single injection of monocrotaline could be attenuated by administration of the shRNA, and concluded that plasmid-based shRNA against CTGF attenuated pulmonary vascular remodeling in monOCrotaline-treated rats. Expand
Lung-Targeted RNA Interference Against Angiopoietin-2 Ameliorates Multiple Organ Dysfunction and Death in Sepsis
TLDR
The Tie2 antagonist angiopoietin-2 represents a promising target against sepsis-associated multiple organ dysfunction and a novel RNA interference therapeutic approach targeting gene expression in the pulmonary endothelium could be a clinically relevant pharmacological strategy to reduce injurious angiopOietIn-2 synthesis. Expand
Serum–Glucocorticoid Regulated Kinase 1 Regulates Macrophage Recruitment and Activation Contributing to Monocrotaline-Induced Pulmonary Arterial Hypertension
TLDR
It is demonstrated thatSGK1 is important to the regulation of macrophage activation that contributes to the development of PAH; thus, SGK1 may be a potential therapeutic target for the treatment ofPAH. Expand
Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
TLDR
Intratracheal transfer of the human PGIS gene augmented pulmonary prostacyclin synthesis, ameliorated MCT-induced pulmonary hypertension, and thereby improved survival in MCT rats. Expand
Coupling factor 6-induced activation of ecto-F1Fo complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice
TLDR
Through its action on the β-subunit of ecto-F1Fo complex, which results in intracellular acidosis, CF6 plays a crucial role in the development of insulin resistance and hypertension, possibly also providing a novel therapeutic target against cardiovascular disease. Expand
AAV Delivery of Tumor Necrosis Factor-&agr; Short Hairpin RNA Attenuates Cold-Induced Pulmonary Hypertension and Pulmonary Arterial Remodeling
TLDR
Upregulation of TNF-&agr; played a critical role in the pathogenesis of cold-induced PH by promoting pulmonary macrophage infiltration and inflammation. Expand
Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
TLDR
It is concluded that the non-specific anti-inflammatory drug DEC affects developing PAH and is partially effective once angioobliterative PAH has been established. Expand
N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
TLDR
LASSBio-1386 is effective at preventing endothelial and RV dysfunction in PAH, a finding that may have important implications for ongoing clinical evaluation of A2AR agonists for the treatment of PAH. Expand
...
1
2
3
4
5
...